Drug profile · INN
apremilast
APREMILAST VIATRIS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
apremilast (APREMILAST VIATRIS) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN apremilast
Brand APREMILAST VIATRIS
Route ORAL
Formulation TABLET, EXTENDED RELEASE
ATC code L04AA32
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is apremilast?
apremilast (APREMILAST VIATRIS) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for apremilast?
APREMILAST VIATRIS is a marketed brand name for apremilast. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of apremilast?
apremilast has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.